期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Drosophila Eyes Absent Homologue 2 is up-regulated in lung adenocarcinoma
1
作者 Juntang Guo Chaoyang Liang +2 位作者 Lihua Ding naikang zhou Qinong Ye 《The Chinese-German Journal of Clinical Oncology》 CAS 2009年第12期681-684,共4页
Objective: Lung cancer has emerged as a leading cause of cancer death in the world. Eyes Absent (EYA) is an important and conserved transcriptional regulator of development. The aim of the present study was to iden... Objective: Lung cancer has emerged as a leading cause of cancer death in the world. Eyes Absent (EYA) is an important and conserved transcriptional regulator of development. The aim of the present study was to identify the expression of Drosophila Eyes Absent Hemologue 2 (EYA2) in non-small cell lung cancer (NSCLC) and to investigate their correlation with clinical parameters. Methods: Fresh, paired lung samples (n = 59) of NSCLC were obtained by surgical resection at the Department of Thoracic Surgery of the People's Liberation Army General Hospital. Expression of EYA2 were examined by Western blot and immunohistochemical analysis in specimens of NSCLC and paired normal lung tissue. Clinical data, pathologic result and Ki67 expression were collected and subsequent correlation with EYA2 expression was analyzed. Results: EYA2 expression was found located in cytoplasm and nucleus, but mostly in cytoplasm. The expression of EYA2 increased in NSCLC by Western blot and immunohistochemistry, which was correlated with histology type, but not correlated with gender, age, pTNM stage, histological differentiation and lymph node metastasis. Compared with normal lung tissue, the expression of EYA2 significantly was up-regulated in lung adenocarcinoma, while no significant difference in lung squamous cell carcinoma. Expression of EYA2 was uncorrelated with expression of Ki67 in NSCLC. Conclusion: Expression of EYA2 was augmented in lung adenocarcinoma. EYA2 is likely participating in tumorigenesis and development of lung adenocarcinoma as transcriptional activator. 展开更多
关键词 Eyes Absent (EYA) Drosophila Eyes Absent Homologue 2 (EYA2) non-small cell lung cancer (NSCLC) KI67
下载PDF
The Use of Multislice Spiral CT to Predict the Resectability of Central Lung Cancer: Correlation with Pathologic and Surgical Findings
2
作者 Yang Liu Yu'e Sun +1 位作者 naikang zhou Qiming Xu 《Chinese Journal of Clinical Oncology》 CSCD 2005年第4期726-730,共5页
OBJECTIVE To assess the accuracy of multi-slice spiral CT (MSCT) with imaging reconstruction in judging central pulmonary vascular involvement from central lung cancer, and to explore its ability to predict the rese... OBJECTIVE To assess the accuracy of multi-slice spiral CT (MSCT) with imaging reconstruction in judging central pulmonary vascular involvement from central lung cancer, and to explore its ability to predict the resectability of lung cancer. METHODS MSCTs were conducted on 48 patients who were diagnosed preoperatively with central lung cancer. Images of pulmonary arteries and veins that might affect Iobectomy or pneumonectomy were reconstructed by means of imaging processing techniques. Then the relationship of the tumor to the vessels was assessed prospectively on both axial CT images and axial CT images plus reconstructed images(CT-RI) in comparison to subsequent pathologic and surgical findings. RESULTS MSCTs were obtained on all 48 patients whom 42 underwent thoracotomy, Iobectomy or pneumonectomy. Compared with the axial CT images, CT-RI was more accurate in judging the relationship of the central pulmonary vessels to the tumor based on subsequent pathologic 78 vessels studied and surgical findings (186 vessels studied)(0.01 〈P〈0.05). The sensitivity and positive predictive value of unresectability of the vessels were all remarkably higher with CT-RI (P〈0.01). CONCLUSION MSCT with imaging reconstruction can improve the recognition of neoplastic invasion of central pulmonary vessels. It can be used to predict preoperatively the resectability of central lung cancer and to plan surgery. 展开更多
关键词 lung neoplasm THORACOTOMY tomography X-ray computed PATHOLOGY
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部